The move was welcomed by the Royal College of General Practitioners, A letter has been sent to all GPs, pharmacists zyban tablet and smoking cessation clinics to advise them of the changes. Business Editors/Medical Writers FORT LAUDERDALE, Fla. --(BUSINESS WIRE)--March 1, 2002 ANDRX CORPORATION -- Andrx Group (Nasdaq:ADRX) today announced that Judge Wilkie D. For more information, please visit the Zyban tablet company's Web site at www. Impaxlabs. Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities zyban tablet litigation Reform Act of 1995.
MORRISTOWN, N. , March 28 Zyban tablet /prnewswire/ --.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this news release contain information that is not historical, these statements are forward-looking in nature zyban tablet and express the beliefs and expectations of management. This agreement with Andrx and Teva provides us with an opportunity to zyban tablet bring our products to the market earlier than would be possible alone. Andrx and IMPAX have both obtained favorable summary judgment zyban tablet decisions that their formulations of the products do not infringe GlaxoSmithKline's patents.
Commenting on the news, zyban tablet elliot F.

IMPAX currently has 20 applications pending at the FDA, including five tentatively approved, which address over $7 billion in U. 47th Avenue, Fort Lauderdale, Florida 33314, 954-584-0300. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Edwards, Chief Executive Officer of zyban tablet impax Laboratories. (NASDAQ NM: zyban tablet ipxl) today announced that Glaxo Wellcome, Inc. , a wholly owned subsidiary of Glaxo Wellcome, plc (NYSE: GLX), has filed a lawsuit against the Company in the Northern District of California alleging patent infringement related to IMPAX's filing of Abbreviated New Drug Applications (ANDA) for generic versions of Wellbutrin SR(R) (bupropion hydrochloride) Sustained-Release Tablets and Zyban(R) (bupropion hydrochloride) Sustained-Release Tablets. Andrx intends to introduce its cost-effective versions of these products into the marketplace when it is practicable, as it did in June 1999 and October 1997, when Andrx began selling bioequivalent versions of Cardizem(R) CD and Dilacor(R) XR. We are very confident that our formulation does not infringe the Glaxo Wellcome patent, said Barry R. Together, these branded products reported 1998 sales in the zyban tablet us in excess of $750 million. The transactions contemplated by the exclusivity transfer agreement are subject to obtaining all necessary zyban tablet government approvals. Subsidiary (NASDAQ: CYBA), is developing internet-based software and applications for the healthcare industry.